Ian El-Mokadem Buys 500 Shares of Diploma PLC (LON:DPLM) Stock

Diploma PLC (LON:DPLM) insider Ian El-Mokadem bought 500 shares of the stock in a transaction dated Monday, March 24th. The stock was purchased at an average price of GBX 3,948 ($50.83) per share, with a total value of £19,740 ($25,415.22).

Diploma Price Performance

Shares of LON:DPLM opened at GBX 3,960 ($50.98) on Thursday. Diploma PLC has a 1 year low of GBX 3,468 ($44.65) and a 1 year high of GBX 4,808 ($61.90). The company has a market capitalization of £5.28 billion, a PE ratio of 45.52, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The business has a fifty day moving average price of GBX 4,379.20 and a two-hundred day moving average price of GBX 4,376.57. The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80.

Diploma Increases Dividend

The business also recently declared a dividend, which was paid on Friday, January 31st. Investors of record on Thursday, January 16th were given a dividend of GBX 42 ($0.54) per share. The ex-dividend date was Thursday, January 16th. This represents a yield of 0.93%. This is a positive change from Diploma’s previous dividend of $17.30. Diploma’s dividend payout ratio is presently 65.52%.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. upped their price objective on shares of Diploma from GBX 4,370 ($56.26) to GBX 4,420 ($56.91) and gave the stock a “neutral” rating in a research report on Tuesday, January 14th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of GBX 4,567.50 ($58.81).

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.